Tilvestamab

Biorbyt

Tilvestamab

10

Research Use Only

Unconjugated

>95%

Tilvestamab (BGB149), a humanized anti-AXL antibody, effectively blocks AXL-mediated cell signaling, significantly reduces Gas6-induced AXL activation, and inhibits downstream AKT phosphorylation in 786-0-Luc RCC cells. This compound is particularly useful in cancer research focusing on renal cell carcinomas with overexpressed AXL [1].

-20°C,2°C to 8°C

12352203